Ocean Bio-Chem - Desinfektion - Kampf gegen Ebola!! - 500 Beiträge pro Seite
eröffnet am 15.10.14 18:01:19 von
neuester Beitrag 18.10.14 17:36:58 von
neuester Beitrag 18.10.14 17:36:58 von
Beiträge: 7
ID: 1.200.688
ID: 1.200.688
Aufrufe heute: 0
Gesamt: 1.872
Gesamt: 1.872
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 10869 | |
vor 52 Minuten | 7927 | |
vor 1 Stunde | 4687 | |
vor 1 Stunde | 4077 | |
vor 1 Stunde | 3623 | |
vor 52 Minuten | 3555 | |
vor 1 Stunde | 2779 | |
heute 20:56 | 2680 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.075,00 | +0,33 | 239 | |||
2. | 34. | 1,3800 | -1,43 | 102 | |||
3. | 4. | 0,1890 | -2,58 | 81 | |||
4. | 3. | 172,20 | +6,21 | 78 | |||
5. | 2. | 9,3325 | -3,69 | 77 | |||
6. | 14. | 7,0010 | +4,17 | 53 | |||
7. | 18. | 22,240 | -3,22 | 40 | |||
8. | 6. | 0,0160 | -24,17 | 38 |
Ocean Bio-Chem könnte der nächste Mitspieler im Ebola-Kampf sein!!!
http://www.nasdaq.com/symbol/obci/real-time
http://www.nasdaq.com/symbol/obci/real-time
Antwort auf Beitrag Nr.: 48.046.300 von kwhistler am 15.10.14 18:01:19Salut Kwhistler
Oh wie schön...Bin hier z.Z All-In
Warum
1.Quelle:http://finance.yahoo.com/news/ocean-bio-chem-inc-reports-130…
Zitate:
OdorStar owns patents relating to a device for producing chlorine dioxide. The Company markets disinfectant products incorporating the device under the brand name Performacide®.
Under the agreement relating to the acquisition of the membership interests, Ocean Bio-Chem provided a cash payment to BBL and released BBL from certain indebtedness and other monetary claims, while BBL released a Company subsidiary from certain royalty claims. BBL was also provided purchase rights with regard to products containing the patented device.
Ocean Bio-Chem, Inc. President and CEO Peter Dornau stated: "The acquisition gives our company complete ownership of OdorStar's patents. In addition, as a result of the agreement, the Company also has exclusive rights to the Performacide® trade name. We are optimistic that Performacide® will begin to contribute to our earnings in 2015."
2.Insider
http://finance.yahoo.com/q/mh?s=OBCI+Major+Holders
3.U.S. EPA Approves Ocean Bio-Chem’s New Liquid Disinfectant, Xtrem-A-Cide P(R) — Effective Against Salmonella, Hepatitis A, Influenza-A, E-Coli, Numerous Other Viruses and Fungi
FORT LAUDERDALE, FL--(Marketwire - Feb 25, 2013) - Ocean Bio-Chem, Inc. (NASDAQ: OBCI), a leading manufacturer and distributor of appearance, performance, and maintenance products serving the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, is pleased to announce the U.S. Environmental Protection Agency approval of Ocean Bio-Chem's new product, Xtrem-A-Cide P®, a broad-spectrum disinfectant that is approved for use as a sanitizer, virucide, tuberculocide, fungicide, algaecide, slimicide and deodorizer.
This new product is an extension of Star brite's OdorStar line of NosGuard® mold and mildew products.
"Xtrem-A-Cide P® utilizes Ocean Bio-Chem's patented technology to generate a chlorine dioxide solution which can be applied as a deep-penetrating spray for easy application," said Peter Dornau, CEO.
Chlorine dioxide is a proven disinfectant and deodorizing agent. It is widely used in municipal water treatment operations, in toothpaste, mouthwashes, and to eliminate bedbugs in hotels. Chlorine dioxide was also the agent used to remediate buildings contaminated in 2001 by Anthrax bacteria and more recently was used to eliminate mold from homes and buildings in New Orleans and the surrounding area that were flooded during Hurricane Katrina.
"The applications and markets for this new product are immense, ranging from home use to hospitals, cruise ships, hotels and other hospitality facilities, gyms, rest rooms, arenas, food processing operations, schools and other facilities," Mr. Dornau explained.
When used as directed, Xtrem-A-Cide P® has been approved for surface eradication of Staphylococcus aureus (MRSA), salmonella, HIV1, Hepatitis A, Herpes Simplex-2, Influenza-A, Rhinovirus Type 37, E-Coli and many more viruses and fungi. While extremely powerful, the new product is designed to be easily applied with a minimum of training.
Xtrem-A-Cide P® will be manufactured in Star brite's 300,000 square foot manufacturing and distribution facility in Montgomery, Alabama, in a recently constructed state-of-the-art "clean room" where the Company is currently manufacturing other chlorine dioxide products designed for marine, RV and automotive use.
"We are enthusiastic about the potential future revenues and profits this product can generate. The addition of Xtrem-A-Cide P® will position Ocean Bio-Chem to continue its rapid expansion into many additional new markets," Mr. Dornau concluded.
About Ocean Bio-Chem, Inc.:
Ocean Bio-Chem, Inc. is principally engaged in the manufacturing, marketing and distribution of a broad line of appearance and maintenance products for boats, recreational vehicles, automobiles, power sports, outdoor power equipment and motorcycle markets under the Star brite® StarTron® and other trademarks within the United States of America and Canada. In addition, the Company produces private label formulations of many of its products for various customers and provides custom blending and packaging services for these and other products.
The Company trades publicly under NASDAQ Capital Markets, Ticker Symbol: OBCI.
The Company's web sites are: www.oceanbiochem.com, www.starbrite.com and www.startron.com and nos-guard.com
Forward-looking Statements:
Certain statements contained in this Press Release including without limitation expectations as to future sales and operating results, constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," "could" including the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry, reliance on certain key customers, changes in consumer demand for marine, recreational vehicle and automotive products, advertising and promotional efforts, exposure to market risks for changes in interest rates and in foreign exchange rates, and other factors.
4.Quelle:http://finance.yahoo.com/news/ocean-bio-chem-inc-reports-130…
Wed, 24 Sep 2014 13:00:00 GMT ~ Ocean Bio-Chem, Inc. Reports Acquisition of Joint Venture Partner's Interest in OdorStar Technology, LLC
[PR Newswire] - FORT LAUDERDALE, Fla., Sept. 24, 2014 /PRNewswire/ -- Ocean Bio-Chem, Inc. (OBCI), announced the acquisition, of the membership interest in OdorStar Technology, LLC. (OdorStar) that it previously did not own from its joint venture partner, BBL Distributors, LLC (BBL). As a result of the acquisition, OdorStar is now a wholly-owned subsidiary of Ocean Bio-Chem. OdorStar owns patents relating to a device for producing chlorine dioxide. The Company markets disinfectant products incorporating the device under the brand name Performacide®. Under the agreement relating to the acquisition of the membership interests, Ocean Bio-Chem provided a cash payment to BBL and released BBL from certain indebtedness and other monetary claims, while BBL released a Company subsidiary from certain royalty claims.
Jetzt:
Also
à bientôt
OC
Oh wie schön...Bin hier z.Z All-In
Warum
1.Quelle:http://finance.yahoo.com/news/ocean-bio-chem-inc-reports-130…
Zitate:
OdorStar owns patents relating to a device for producing chlorine dioxide. The Company markets disinfectant products incorporating the device under the brand name Performacide®.
Under the agreement relating to the acquisition of the membership interests, Ocean Bio-Chem provided a cash payment to BBL and released BBL from certain indebtedness and other monetary claims, while BBL released a Company subsidiary from certain royalty claims. BBL was also provided purchase rights with regard to products containing the patented device.
Ocean Bio-Chem, Inc. President and CEO Peter Dornau stated: "The acquisition gives our company complete ownership of OdorStar's patents. In addition, as a result of the agreement, the Company also has exclusive rights to the Performacide® trade name. We are optimistic that Performacide® will begin to contribute to our earnings in 2015."
2.Insider
http://finance.yahoo.com/q/mh?s=OBCI+Major+Holders
3.U.S. EPA Approves Ocean Bio-Chem’s New Liquid Disinfectant, Xtrem-A-Cide P(R) — Effective Against Salmonella, Hepatitis A, Influenza-A, E-Coli, Numerous Other Viruses and Fungi
FORT LAUDERDALE, FL--(Marketwire - Feb 25, 2013) - Ocean Bio-Chem, Inc. (NASDAQ: OBCI), a leading manufacturer and distributor of appearance, performance, and maintenance products serving the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, is pleased to announce the U.S. Environmental Protection Agency approval of Ocean Bio-Chem's new product, Xtrem-A-Cide P®, a broad-spectrum disinfectant that is approved for use as a sanitizer, virucide, tuberculocide, fungicide, algaecide, slimicide and deodorizer.
This new product is an extension of Star brite's OdorStar line of NosGuard® mold and mildew products.
"Xtrem-A-Cide P® utilizes Ocean Bio-Chem's patented technology to generate a chlorine dioxide solution which can be applied as a deep-penetrating spray for easy application," said Peter Dornau, CEO.
Chlorine dioxide is a proven disinfectant and deodorizing agent. It is widely used in municipal water treatment operations, in toothpaste, mouthwashes, and to eliminate bedbugs in hotels. Chlorine dioxide was also the agent used to remediate buildings contaminated in 2001 by Anthrax bacteria and more recently was used to eliminate mold from homes and buildings in New Orleans and the surrounding area that were flooded during Hurricane Katrina.
"The applications and markets for this new product are immense, ranging from home use to hospitals, cruise ships, hotels and other hospitality facilities, gyms, rest rooms, arenas, food processing operations, schools and other facilities," Mr. Dornau explained.
When used as directed, Xtrem-A-Cide P® has been approved for surface eradication of Staphylococcus aureus (MRSA), salmonella, HIV1, Hepatitis A, Herpes Simplex-2, Influenza-A, Rhinovirus Type 37, E-Coli and many more viruses and fungi. While extremely powerful, the new product is designed to be easily applied with a minimum of training.
Xtrem-A-Cide P® will be manufactured in Star brite's 300,000 square foot manufacturing and distribution facility in Montgomery, Alabama, in a recently constructed state-of-the-art "clean room" where the Company is currently manufacturing other chlorine dioxide products designed for marine, RV and automotive use.
"We are enthusiastic about the potential future revenues and profits this product can generate. The addition of Xtrem-A-Cide P® will position Ocean Bio-Chem to continue its rapid expansion into many additional new markets," Mr. Dornau concluded.
About Ocean Bio-Chem, Inc.:
Ocean Bio-Chem, Inc. is principally engaged in the manufacturing, marketing and distribution of a broad line of appearance and maintenance products for boats, recreational vehicles, automobiles, power sports, outdoor power equipment and motorcycle markets under the Star brite® StarTron® and other trademarks within the United States of America and Canada. In addition, the Company produces private label formulations of many of its products for various customers and provides custom blending and packaging services for these and other products.
The Company trades publicly under NASDAQ Capital Markets, Ticker Symbol: OBCI.
The Company's web sites are: www.oceanbiochem.com, www.starbrite.com and www.startron.com and nos-guard.com
Forward-looking Statements:
Certain statements contained in this Press Release including without limitation expectations as to future sales and operating results, constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," "could" including the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry, reliance on certain key customers, changes in consumer demand for marine, recreational vehicle and automotive products, advertising and promotional efforts, exposure to market risks for changes in interest rates and in foreign exchange rates, and other factors.
4.Quelle:http://finance.yahoo.com/news/ocean-bio-chem-inc-reports-130…
Wed, 24 Sep 2014 13:00:00 GMT ~ Ocean Bio-Chem, Inc. Reports Acquisition of Joint Venture Partner's Interest in OdorStar Technology, LLC
[PR Newswire] - FORT LAUDERDALE, Fla., Sept. 24, 2014 /PRNewswire/ -- Ocean Bio-Chem, Inc. (OBCI), announced the acquisition, of the membership interest in OdorStar Technology, LLC. (OdorStar) that it previously did not own from its joint venture partner, BBL Distributors, LLC (BBL). As a result of the acquisition, OdorStar is now a wholly-owned subsidiary of Ocean Bio-Chem. OdorStar owns patents relating to a device for producing chlorine dioxide. The Company markets disinfectant products incorporating the device under the brand name Performacide®. Under the agreement relating to the acquisition of the membership interests, Ocean Bio-Chem provided a cash payment to BBL and released BBL from certain indebtedness and other monetary claims, while BBL released a Company subsidiary from certain royalty claims.
Jetzt:
Also
à bientôt
OC
Antwort auf Beitrag Nr.: 48.046.789 von kwhistler am 15.10.14 18:40:34Salut
Na...
Ich vermute es wird bald geprüft---> des Sprühen von Pfleger mit einer Desinfektant, die den tödlichen Virus neutralisieren konnte.
Ich dachte es wäre Pflicht .......................................... ........................
deswegen könnte Desinfektion Duschen zu Schütz von Helfer dafür sorgen das man sich nicht anstecken bei ausziehen von infiziertes Schütz Anzüge...
Also abwarten ...und ich bin jetzt 25 % in minus...
à bientôt
OC
Nur m.Meinung
Na...
Ich vermute es wird bald geprüft---> des Sprühen von Pfleger mit einer Desinfektant, die den tödlichen Virus neutralisieren konnte.
Ich dachte es wäre Pflicht .......................................... ........................
deswegen könnte Desinfektion Duschen zu Schütz von Helfer dafür sorgen das man sich nicht anstecken bei ausziehen von infiziertes Schütz Anzüge...
Also abwarten ...und ich bin jetzt 25 % in minus...
à bientôt
OC
Nur m.Meinung
Antwort auf Beitrag Nr.: 48.049.726 von occitania am 15.10.14 22:26:43
Das ist heute nicht schlecht für den Anfang!!!
Das ist heute nicht schlecht für den Anfang!!!
Antwort auf Beitrag Nr.: 48.060.055 von kwhistler am 16.10.14 20:46:04Moin kwhistler
sag mal, wer hat denn diesen schlampigen Thread eröffnet
keine Verlinkung zur Aktie, also das geht gar nicht.
Mir erschließt sich nicht so ganz, was dieses Unternehmen mit Ebola zu tun hat!
"OBCI is a leading manufacturer and distributor of maintenance and appearance products for the marine, automotive, recreational vehicle and home care markets throughout North America."
Könntest du mir mal bitte ein kleines Update geben, was hier das Zugpferd werden wird.
Zumindest schreibt die Firma schwarze Zahlen
http://oceanbiochem.com/obci/images/pdf/AR-2013.pdf
Anke im Voraus
sag mal, wer hat denn diesen schlampigen Thread eröffnet
keine Verlinkung zur Aktie, also das geht gar nicht.
Mir erschließt sich nicht so ganz, was dieses Unternehmen mit Ebola zu tun hat!
"OBCI is a leading manufacturer and distributor of maintenance and appearance products for the marine, automotive, recreational vehicle and home care markets throughout North America."
Könntest du mir mal bitte ein kleines Update geben, was hier das Zugpferd werden wird.
Zumindest schreibt die Firma schwarze Zahlen
http://oceanbiochem.com/obci/images/pdf/AR-2013.pdf
Anke im Voraus
Antwort auf Beitrag Nr.: 48.074.377 von reaaalist am 18.10.14 17:28:48Achso,
habe gerade Occi seinen Artikel gesehen!
Ozean Bio-Chem, Inc. meldet Akquisition von Joint-Venture-Partner Interesse an OdorStar Technology, LLC
Hm. mal sehen ob ich bei Schwäche einige Taler riskiere.
Sauber ist der Laden ja
habe gerade Occi seinen Artikel gesehen!
Ozean Bio-Chem, Inc. meldet Akquisition von Joint-Venture-Partner Interesse an OdorStar Technology, LLC
Hm. mal sehen ob ich bei Schwäche einige Taler riskiere.
Sauber ist der Laden ja
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
241 | ||
93 | ||
83 | ||
77 | ||
73 | ||
53 | ||
45 | ||
38 | ||
37 | ||
34 |
Wertpapier | Beiträge | |
---|---|---|
33 | ||
30 | ||
26 | ||
25 | ||
24 | ||
24 | ||
24 | ||
23 | ||
19 | ||
19 |